Pressurized Metered-dose Inhaler Market - Global Outlook and Forecast 2022-2028

Pressurized Metered-dose Inhaler Market - Global Outlook and Forecast 2022-2028

Report Code: KNJ1096479 | No. of Pages: 79 | Category: Medical Devices
Publisher: Market Monitor Global | Date of Publish: Jan-2022
This report contains market size and forecasts of Pressurized Metered-dose Inhaler in global, including the following market information:
Global Pressurized Metered-dose Inhaler Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pressurized Metered-dose Inhaler Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Pressurized Metered-dose Inhaler companies in 2021 (%)
The global Pressurized Metered-dose Inhaler market was valued at 6205.4 million in 2021 and is projected to reach US$ 7779.6 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Single-dose Inhalers Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pressurized Metered-dose Inhaler include Glenmark Pharmaceuticals(India), Novartis International AG(Switzerland), Propeller Health(USA), AstraZeneca Plc(Sweden), Philips Respironics(Netherlands), Teva Pharmaceutical Industries(Israel), Opko Health(USA), Merck(USA) and BioCare Group(Malaysia). etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pressurized Metered-dose Inhaler manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pressurized Metered-dose Inhaler Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Pressurized Metered-dose Inhaler Market Segment Percentages, by Type, 2021 (%)
    Single-dose Inhalers
    Multi-dose Inhalers
Global Pressurized Metered-dose Inhaler Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Pressurized Metered-dose Inhaler Market Segment Percentages, by Application, 2021 (%)
    Hospitals
    Ambulatory Surgery Centres
Global Pressurized Metered-dose Inhaler Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Pressurized Metered-dose Inhaler Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pressurized Metered-dose Inhaler revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pressurized Metered-dose Inhaler revenues share in global market, 2021 (%)
Key companies Pressurized Metered-dose Inhaler sales in global market, 2017-2022 (Estimated), (Units)
Key companies Pressurized Metered-dose Inhaler sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Glenmark Pharmaceuticals(India)
    Novartis International AG(Switzerland)
    Propeller Health(USA)
    AstraZeneca Plc(Sweden)
    Philips Respironics(Netherlands)
    Teva Pharmaceutical Industries(Israel)
    Opko Health(USA)
    Merck(USA)
    BioCare Group(Malaysia)
1 Introduction to Research & Analysis Reports
    1.1 Pressurized Metered-dose Inhaler Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Pressurized Metered-dose Inhaler Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Pressurized Metered-dose Inhaler Overall Market Size
    2.1 Global Pressurized Metered-dose Inhaler Market Size: 2021 VS 2028
    2.2 Global Pressurized Metered-dose Inhaler Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Pressurized Metered-dose Inhaler Sales: 2017-2028
3 Company Landscape
    3.1 Top Pressurized Metered-dose Inhaler Players in Global Market
    3.2 Top Global Pressurized Metered-dose Inhaler Companies Ranked by Revenue
    3.3 Global Pressurized Metered-dose Inhaler Revenue by Companies
    3.4 Global Pressurized Metered-dose Inhaler Sales by Companies
    3.5 Global Pressurized Metered-dose Inhaler Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Pressurized Metered-dose Inhaler Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Pressurized Metered-dose Inhaler Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Pressurized Metered-dose Inhaler Players in Global Market
        3.8.1 List of Global Tier 1 Pressurized Metered-dose Inhaler Companies
        3.8.2 List of Global Tier 2 and Tier 3 Pressurized Metered-dose Inhaler Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Pressurized Metered-dose Inhaler Market Size Markets, 2021 & 2028
        4.1.2 Single-dose Inhalers
        4.1.3 Multi-dose Inhalers
    4.2 By Type - Global Pressurized Metered-dose Inhaler Revenue & Forecasts
        4.2.1 By Type - Global Pressurized Metered-dose Inhaler Revenue, 2017-2022
        4.2.2 By Type - Global Pressurized Metered-dose Inhaler Revenue, 2023-2028
        4.2.3 By Type - Global Pressurized Metered-dose Inhaler Revenue Market Share, 2017-2028
    4.3 By Type - Global Pressurized Metered-dose Inhaler Sales & Forecasts
        4.3.1 By Type - Global Pressurized Metered-dose Inhaler Sales, 2017-2022
        4.3.2 By Type - Global Pressurized Metered-dose Inhaler Sales, 2023-2028
        4.3.3 By Type - Global Pressurized Metered-dose Inhaler Sales Market Share, 2017-2028
    4.4 By Type - Global Pressurized Metered-dose Inhaler Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Pressurized Metered-dose Inhaler Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Ambulatory Surgery Centres
    5.2 By Application - Global Pressurized Metered-dose Inhaler Revenue & Forecasts
        5.2.1 By Application - Global Pressurized Metered-dose Inhaler Revenue, 2017-2022
        5.2.2 By Application - Global Pressurized Metered-dose Inhaler Revenue, 2023-2028
        5.2.3 By Application - Global Pressurized Metered-dose Inhaler Revenue Market Share, 2017-2028
    5.3 By Application - Global Pressurized Metered-dose Inhaler Sales & Forecasts
        5.3.1 By Application - Global Pressurized Metered-dose Inhaler Sales, 2017-2022
        5.3.2 By Application - Global Pressurized Metered-dose Inhaler Sales, 2023-2028
        5.3.3 By Application - Global Pressurized Metered-dose Inhaler Sales Market Share, 2017-2028
    5.4 By Application - Global Pressurized Metered-dose Inhaler Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Pressurized Metered-dose Inhaler Market Size, 2021 & 2028
    6.2 By Region - Global Pressurized Metered-dose Inhaler Revenue & Forecasts
        6.2.1 By Region - Global Pressurized Metered-dose Inhaler Revenue, 2017-2022
        6.2.2 By Region - Global Pressurized Metered-dose Inhaler Revenue, 2023-2028
        6.2.3 By Region - Global Pressurized Metered-dose Inhaler Revenue Market Share, 2017-2028
    6.3 By Region - Global Pressurized Metered-dose Inhaler Sales & Forecasts
        6.3.1 By Region - Global Pressurized Metered-dose Inhaler Sales, 2017-2022
        6.3.2 By Region - Global Pressurized Metered-dose Inhaler Sales, 2023-2028
        6.3.3 By Region - Global Pressurized Metered-dose Inhaler Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Pressurized Metered-dose Inhaler Revenue, 2017-2028
        6.4.2 By Country - North America Pressurized Metered-dose Inhaler Sales, 2017-2028
        6.4.3 US Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.4.4 Canada Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.4.5 Mexico Pressurized Metered-dose Inhaler Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Pressurized Metered-dose Inhaler Revenue, 2017-2028
        6.5.2 By Country - Europe Pressurized Metered-dose Inhaler Sales, 2017-2028
        6.5.3 Germany Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.5.4 France Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.5.5 U.K. Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.5.6 Italy Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.5.7 Russia Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.5.8 Nordic Countries Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.5.9 Benelux Pressurized Metered-dose Inhaler Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Pressurized Metered-dose Inhaler Revenue, 2017-2028
        6.6.2 By Region - Asia Pressurized Metered-dose Inhaler Sales, 2017-2028
        6.6.3 China Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.6.4 Japan Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.6.5 South Korea Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.6.6 Southeast Asia Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.6.7 India Pressurized Metered-dose Inhaler Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Pressurized Metered-dose Inhaler Revenue, 2017-2028
        6.7.2 By Country - South America Pressurized Metered-dose Inhaler Sales, 2017-2028
        6.7.3 Brazil Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.7.4 Argentina Pressurized Metered-dose Inhaler Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Pressurized Metered-dose Inhaler Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Pressurized Metered-dose Inhaler Sales, 2017-2028
        6.8.3 Turkey Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.8.4 Israel Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.8.5 Saudi Arabia Pressurized Metered-dose Inhaler Market Size, 2017-2028
        6.8.6 UAE Pressurized Metered-dose Inhaler Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Glenmark Pharmaceuticals(India)
        7.1.1 Glenmark Pharmaceuticals(India) Corporate Summary
        7.1.2 Glenmark Pharmaceuticals(India) Business Overview
        7.1.3 Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Major Product Offerings
        7.1.4 Glenmark Pharmaceuticals(India) Pressurized Metered-dose Inhaler Sales and Revenue in Global (2017-2022)
        7.1.5 Glenmark Pharmaceuticals(India) Key News
    7.2 Novartis International AG(Switzerland)
        7.2.1 Novartis International AG(Switzerland) Corporate Summary
        7.2.2 Novartis International AG(Switzerland) Business Overview
        7.2.3 Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Major Product Offerings
        7.2.4 Novartis International AG(Switzerland) Pressurized Metered-dose Inhaler Sales and Revenue in Global (2017-2022)
        7.2.5 Novartis International AG(Switzerland) Key News
    7.3 Propeller Health(USA)
        7.3.1 Propeller Health(USA) Corporate Summary
        7.3.2 Propeller Health(USA) Business Overview
        7.3.3 Propeller Health(USA) Pressurized Metered-dose Inhaler Major Product Offerings
        7.3.4 Propeller Health(USA) Pressurized Metered-dose Inhaler Sales and Revenue in Global (2017-2022)
        7.3.5 Propeller Health(USA) Key News
    7.4 AstraZeneca Plc(Sweden)
        7.4.1 AstraZeneca Plc(Sweden) Corporate Summary
        7.4.2 AstraZeneca Plc(Sweden) Business Overview
        7.4.3 AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Major Product Offerings
        7.4.4 AstraZeneca Plc(Sweden) Pressurized Metered-dose Inhaler Sales and Revenue in Global (2017-2022)
        7.4.5 AstraZeneca Plc(Sweden) Key News
    7.5 Philips Respironics(Netherlands)
        7.5.1 Philips Respironics(Netherlands) Corporate Summary
        7.5.2 Philips Respironics(Netherlands) Business Overview
        7.5.3 Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Major Product Offerings
        7.5.4 Philips Respironics(Netherlands) Pressurized Metered-dose Inhaler Sales and Revenue in Global (2017-2022)
        7.5.5 Philips Respironics(Netherlands) Key News
    7.6 Teva Pharmaceutical Industries(Israel)
        7.6.1 Teva Pharmaceutical Industries(Israel) Corporate Summary
        7.6.2 Teva Pharmaceutical Industries(Israel) Business Overview
        7.6.3 Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Major Product Offerings
        7.6.4 Teva Pharmaceutical Industries(Israel) Pressurized Metered-dose Inhaler Sales and Revenue in Global (2017-2022)
        7.6.5 Teva Pharmaceutical Industries(Israel) Key News
    7.7 Opko Health(USA)
        7.7.1 Opko Health(USA) Corporate Summary
        7.7.2 Opko Health(USA) Business Overview
        7.7.3 Opko Health(USA) Pressurized Metered-dose Inhaler Major Product Offerings
        7.7.4 Opko Health(USA) Pressurized Metered-dose Inhaler Sales and Revenue in Global (2017-2022)
        7.7.5 Opko Health(USA) Key News
    7.8 Merck(USA)
        7.8.1 Merck(USA) Corporate Summary
        7.8.2 Merck(USA) Business Overview
        7.8.3 Merck(USA) Pressurized Metered-dose Inhaler Major Product Offerings
        7.8.4 Merck(USA) Pressurized Metered-dose Inhaler Sales and Revenue in Global (2017-2022)
        7.8.5 Merck(USA) Key News
    7.9 BioCare Group(Malaysia)
        7.9.1 BioCare Group(Malaysia) Corporate Summary
        7.9.2 BioCare Group(Malaysia) Business Overview
        7.9.3 BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Major Product Offerings
        7.9.4 BioCare Group(Malaysia) Pressurized Metered-dose Inhaler Sales and Revenue in Global (2017-2022)
        7.9.5 BioCare Group(Malaysia) Key News
8 Global Pressurized Metered-dose Inhaler Production Capacity, Analysis
    8.1 Global Pressurized Metered-dose Inhaler Production Capacity, 2017-2028
    8.2 Pressurized Metered-dose Inhaler Production Capacity of Key Manufacturers in Global Market
    8.3 Global Pressurized Metered-dose Inhaler Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Pressurized Metered-dose Inhaler Supply Chain Analysis
    10.1 Pressurized Metered-dose Inhaler Industry Value Chain
    10.2 Pressurized Metered-dose Inhaler Upstream Market
    10.3 Pressurized Metered-dose Inhaler Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Pressurized Metered-dose Inhaler Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com